Anti-arthritic effect of methotrexate: is it really mediated by adenosine?
- 1 February 2000
- journal article
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 9 (4) , 333-343
- https://doi.org/10.1016/s0928-0987(99)00073-1
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Molecular therapeutics. Methotrexate and its mechanism of actionArthritis & Rheumatism, 1996
- ROLE OF CYTOKINES IN RHEUMATOID ARTHRITISAnnual Review of Immunology, 1996
- Adverse Events in Methotrexate-Treated Rheumatoid Arthritis PatientsRheumatology, 1995
- Methotrexate in Rheumatoid ArthritisDrugs, 1994
- The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation.Journal of Clinical Investigation, 1993
- The effects of (R)-N-(1-methyl-2-phenylethyl) adenosine (L-PIA), a standard A1-selective adenosine agonist on rat acute models of inflammation and neutrophil functionInflammation Research, 1991
- Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart.Circulation, 1991
- The in vitro effects of methotrexate on peripheral blood mononuclear cells: Modulation by methyl donors and spermidineArthritis & Rheumatism, 1990
- Macrophages and Dendritic Cells during the Early Stages of Antigen‐Induced Arthritis in Rats: Immunohistochemical Analysis of Cryostat Sections of the Whole Knee JointScandinavian Journal of Immunology, 1989
- 3,7-Dimethyl-1-propargylxanthine: A potent and selective in vivo antagonist of adenosine analogsLife Sciences, 1988